Intravenous infusion pump is a medical device used to infuse medications or nutrients into a patients circulatory system. These are commonly found in a medical setting as they are widely used in transferring medications in accurate dosages. Key factors that drive the market are increase in geriatric population and rise in prevalence of chronic diseases. In addition, growth in adoption of portable infusion pumps to reduce hospital expenditure also is expected to supplement the growth. However, patient safety risks and medication errors related to infusion pumps may restrict this growth. Moreover, technological advancements in infusion pumps are expected to create lucrative opportunities for key market players.

The global intravenous infusion pump market is segmented based on product, application, and region. Based on product, it is bifurcated into devices and accessories. The devices segment is further subsegmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps. Further, based on application, this market is divided into chemotherapy, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players, such as Becton, Dickinson and Company, Baxter International, Inc., Pfizer Inc., B. Braun Melsungen AG, Fresenius SE & CO. KGaA, Medtronic plc, Smiths Group plc, Terumo Corporation, F. Hoffmann-la Roche Ltd., and Johnson & Johnson, are also provided in this report.

Key Benefits

• This report provides an extensive analysis of the current and emerging trends and dynamics in the global intravenous infusion pump market.
• In-depth analysis is done by constructing market estimations for the key market segments between 2017 and 2023 to identify the prevailing market opportunities.
• This study evaluates the competitive landscape and value chain to understand the competitive environment across the geographies.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these geographies.

Intravenous Infusion Pump Market Key Segments:

By Product

• Devices
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Insulin Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
• Accessories

By Application

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

CHAPTER 4 INTRAVENOUS INFUSION PUMP MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Volumetric infusion pumps

4.2.3.1.1. Market size and forecast

4.2.3.2. Syringe Infusion Pumps

4.2.3.2.1. Market size and forecast

4.2.3.3. Insulin Infusion Pumps

4.2.3.3.1. Market size and forecast

4.2.3.4. Enteral Infusion Pumps

4.2.3.4.1. Market size and forecast

4.2.3.5. Ambulatory Infusion Pumps

4.2.3.5.1. Market size and forecast

4.2.3.6. Patient-Controlled Analgesia Infusion Pumps

4.2.3.6.1. Market size and forecast

4.2.3.7. Implantable Infusion Pumps

4.2.3.7.1. Market size and forecast

4.3. ACCESSORIES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CHEMOTHERAPY

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. DIABETES

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast

5.4. GASTROENTEROLOGY

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast

5.5. ANALGESIA/PAIN MANAGEMENT

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast

5.6. PEDIATRICS/NEONATOLOGY

5.6.1. Key market trends
5.6.2. Growth factors and opportunities
5.6.3. Market size and forecast

5.7. HEMATOLOGY

5.7.1. Key market trends
5.7.2. Growth factors and opportunities
5.7.3. Market size and forecast

5.8. OTHERS

5.8.1. Key market trends
5.8.2. Growth factors and opportunities
5.8.3. Market size and forecast

CHAPTER 6 INTRAVENOUS INFUSION PUMP MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Intravenous Infusion Pump Market by Product 
6.2.5. North America Intravenous Infusion Pump Market by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast

6.3.4. Europe Intravenous Infusion Pump Market by Product 
6.3.5. Europe Intravenous Infusion Pump Market by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Intravenous Infusion Pump Market by Product 
6.4.5. Asia-Pacific Intravenous Infusion Pump Market by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Intravenous Infusion Pump Market by Product 
6.5.5. LAMEA Intravenous Infusion Pump Market by Application

CHAPTER 7 COMPANY PROFILES

7.1. BECTON, DICKINSON AND COMPANY

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. BAXTER INTERNATIONAL, INC.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. PFIZER INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. B. BRAUN MELSUNGEN AG

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. FRESENIUS SE & CO. KGAA

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. MEDTRONIC PLC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. SMITHS GROUP PLC

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. TERUMO CORPORATION

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. F. HOFFMANN-LA ROCHE LTD.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. JOHNSON & JOHNSON

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments